These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32819260)

  • 1. Endogenous Bufadienolide, Blood Pressure and Alcohol Withdrawal.
    Kashkin VA; Egorov AY; Krupitsky EM; Bagrov AY
    Curr Hypertens Rev; 2021; 17(2):170-173. PubMed ID: 32819260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous bufadienolide mediates pressor response to ethanol withdrawal in rats.
    Kashkin VA; Zvartau EE; Fedorova OV; Bagrov YY; Lakatta EG; Bagrov AY
    Eur Neuropsychopharmacol; 2008 Jan; 18(1):74-7. PubMed ID: 17683916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.
    Fedorova OV; Simbirtsev AS; Kolodkin NI; Kotov AY; Agalakova NI; Kashkin VA; Tapilskaya NI; Bzhelyansky A; Reznik VA; Frolova EV; Nikitina ER; Budny GV; Longo DL; Lakatta EG; Bagrov AY
    J Hypertens; 2008 Dec; 26(12):2414-25. PubMed ID: 19008721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
    Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
    Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats.
    Fedorova OV; Agalakova NI; Talan MI; Lakatta EG; Bagrov AY
    J Hypertens; 2005 Aug; 23(8):1515-23. PubMed ID: 16003178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma level of the endogenous sodium pump ligand marinobufagenin is related to the salt-sensitivity in men.
    Fedorova OV; Lakatta EG; Bagrov AY; Melander O
    J Hypertens; 2015 Mar; 33(3):534-41; discussion 541. PubMed ID: 25479026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marinobufagenin in Urine: A Potential Marker of Predisposition to Ethanol and a Target for Spironolactone.
    Kashkin VA; Shekunova EV; Egorov AY; Bagrov AY
    Curr Hypertens Rev; 2018; 14(1):35-38. PubMed ID: 29437012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody against Na/K-ATPase Inhibitor Lowers Blood Pressure and Increases Vascular Fli1 in Experimental Preeclampsia.
    Agalakova NI; Reznik VA; Nadei OV; Ershov IA; Rassokha OS; Vasyutina ML; Ivanov DO; Adair CD; Galagudza MM; Bagrov AY
    Am J Hypertens; 2020 May; 33(6):514-519. PubMed ID: 31713584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous cardiotonic steroids in chronic renal failure.
    Kolmakova EV; Haller ST; Kennedy DJ; Isachkina AN; Budny GV; Frolova EV; Piecha G; Nikitina ER; Malhotra D; Fedorova OV; Shapiro JI; Bagrov AY
    Nephrol Dial Transplant; 2011 Sep; 26(9):2912-9. PubMed ID: 21292813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia.
    Fedorova OV; Ishkaraeva VV; Grigorova YN; Reznik VA; Kolodkin NI; Zazerskaya IE; Zernetkina V; Agalakova NI; Tapilskaya NI; Adair CD; Lakatta EG; Bagrov AY
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30104471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of marinobufagenin in a rat model of human preeclampsia.
    Vu HV; Ianosi-Irimie MR; Pridjian CA; Whitbred JM; Durst JM; Bagrov AY; Fedorova OV; Pridjian G; Puschett JB
    Am J Nephrol; 2005; 25(5):520-8. PubMed ID: 16179779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives.
    Anderson DE; Fedorova OV; Morrell CH; Longo DL; Kashkin VA; Metzler JD; Bagrov AY; Lakatta EG
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1248-54. PubMed ID: 18287222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous cardiotonic steroids and differential patterns of sodium pump inhibition in NaCl-loaded salt-sensitive and normotensive rats.
    Bagrov AY; Agalakova NI; Kashkin VA; Fedorova OV
    Am J Hypertens; 2009 May; 22(5):559-63. PubMed ID: 19229192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity.
    Fridman AI; Matveev SA; Agalakova NI; Fedorova OV; Lakatta EG; Bagrov AY
    J Hypertens; 2002 Jun; 20(6):1189-94. PubMed ID: 12023690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiotonic Steroids Induce Vascular Fibrosis Via Pressure-Independent Mechanism in NaCl-Loaded Diabetic Rats.
    Fedorova OV; Fadeev AV; Grigorova YN; Marshall CA; Zernetkina V; Kolodkin NI; Agalakova NI; Konradi AO; Lakatta EG; Bagrov AY
    J Cardiovasc Pharmacol; 2019 Nov; 74(5):436-442. PubMed ID: 31415452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists.
    Fedorova OV; Emelianov IV; Bagrov KA; Grigorova YN; Wei W; Juhasz O; Frolova EV; Marshall CA; Lakatta EG; Konradi AO; Bagrov AY
    J Hypertens; 2015 Aug; 33(8):1602-10. PubMed ID: 26136067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats.
    Fedorova OV; Lakatta EG; Bagrov AY
    Circulation; 2000 Dec; 102(24):3009-14. PubMed ID: 11113054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic Signaling.
    Haller ST; Yan Y; Drummond CA; Xie J; Tian J; Kennedy DJ; Shilova VY; Xie Z; Liu J; Cooper CJ; Malhotra D; Shapiro JI; Fedorova OV; Bagrov AY
    J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27694325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.